title: [Immunohistological study of the mechanism of cytotoxic effect against cutaneous metastatic malignant melanoma by intralesional injection with anti-monosialoganglioside mouse monoclonal antibody (MAb 202)].
authors.forename: T
authors.initials: T
authors.lastname: Ota
authors.forename: T
authors.initials: T
authors.lastname: Imamura
authors.forename: S
authors.initials: S
authors.lastname: Hamanaka
authors.forename: K
authors.initials: K
authors.lastname: Nishioka
authors.forename: T
authors.initials: T
authors.lastname: Tai
authors.forename: I
authors.initials: I
authors.lastname: Kawashima
authors.forename: R F
authors.initials: RF
authors.lastname: Irie
authors.forename: C
authors.initials: C
authors.lastname: Asagami
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003165:Complement System Proteins / Q000502:physiology; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000627:therapeutic use; D007279:Injections, Subcutaneous; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal; D005732:Gangliosides; D007075:Immunoglobulin M; C025447:sialogangliosides; D003165:Complement System Proteins